Cargando…

Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma

BACKGROUND: Keratoacanthoma (KA) is a rapidly growing epithelial tumour with histopathologic and clinical features similar to squamous cell carcinoma (SCC) and a certain tendency toward spontaneous regression. CASE PRESENTATION: This article presents a unique and rare case of keratoacanthoma arising...

Descripción completa

Detalles Bibliográficos
Autores principales: Pancevski, Goran, Pepic, Senada, Idoska, Sanela, Tofoski, Gligor, Nikolovska, Suzana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874379/
https://www.ncbi.nlm.nih.gov/pubmed/29610614
http://dx.doi.org/10.3889/oamjms.2018.133
_version_ 1783310155657510912
author Pancevski, Goran
Pepic, Senada
Idoska, Sanela
Tofoski, Gligor
Nikolovska, Suzana
author_facet Pancevski, Goran
Pepic, Senada
Idoska, Sanela
Tofoski, Gligor
Nikolovska, Suzana
author_sort Pancevski, Goran
collection PubMed
description BACKGROUND: Keratoacanthoma (KA) is a rapidly growing epithelial tumour with histopathologic and clinical features similar to squamous cell carcinoma (SCC) and a certain tendency toward spontaneous regression. CASE PRESENTATION: This article presents a unique and rare case of keratoacanthoma arising from the upper lip of a young male patient. These two features are in contrast to most of the reported cases in elder male individuals and on the lower lip. Relevant management protocol of the case has also been discussed. CONCLUSION: The article emphasises the significance of discerning such lesions from squamous cell carcinoma thus carrying diagnostic and therapeutic implications. However, in case of the dilemma it is prudent to assume that the lesion is SCC unless proved otherwise clinically and histologically.
format Online
Article
Text
id pubmed-5874379
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Republic of Macedonia
record_format MEDLINE/PubMed
spelling pubmed-58743792018-04-02 Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma Pancevski, Goran Pepic, Senada Idoska, Sanela Tofoski, Gligor Nikolovska, Suzana Open Access Maced J Med Sci Case Report BACKGROUND: Keratoacanthoma (KA) is a rapidly growing epithelial tumour with histopathologic and clinical features similar to squamous cell carcinoma (SCC) and a certain tendency toward spontaneous regression. CASE PRESENTATION: This article presents a unique and rare case of keratoacanthoma arising from the upper lip of a young male patient. These two features are in contrast to most of the reported cases in elder male individuals and on the lower lip. Relevant management protocol of the case has also been discussed. CONCLUSION: The article emphasises the significance of discerning such lesions from squamous cell carcinoma thus carrying diagnostic and therapeutic implications. However, in case of the dilemma it is prudent to assume that the lesion is SCC unless proved otherwise clinically and histologically. Republic of Macedonia 2018-03-08 /pmc/articles/PMC5874379/ /pubmed/29610614 http://dx.doi.org/10.3889/oamjms.2018.133 Text en Copyright: © 2018 Brikene Elshani, Heroid Arifi, Armond Daci. http://creativecommons.org/licenses/CC BY-NC/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
spellingShingle Case Report
Pancevski, Goran
Pepic, Senada
Idoska, Sanela
Tofoski, Gligor
Nikolovska, Suzana
Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma
title Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma
title_full Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma
title_fullStr Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma
title_full_unstemmed Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma
title_short Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma
title_sort topical imiquimod 5% as a treatment option in solitary facial keratoacanthoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874379/
https://www.ncbi.nlm.nih.gov/pubmed/29610614
http://dx.doi.org/10.3889/oamjms.2018.133
work_keys_str_mv AT pancevskigoran topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma
AT pepicsenada topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma
AT idoskasanela topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma
AT tofoskigligor topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma
AT nikolovskasuzana topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma